title: NOX1, 2, 4, 5: counting out oxidative stress.
abstract: For decades, oxidative stress has been discussed as a key mechanism of endothelial dysfunction and cardiovascular disease. However, attempts to validate and exploit this hypothesis clinically by supplementing antioxidants have failed. Nevertheless, this does not disprove the oxidative stress hypothesis. As a certain degree of reactive oxygen species (ROS) formation appears to be physiological and beneficial. To reduce oxidative stress therapeutically, two alternative approaches are being developed. One is the repair of key signalling components that are compromised by oxidative stress. These include uncoupled endothelial nitric oxide (NO) synthase and oxidized/heme-free NO receptor soluble guanylate cyclase. A second approach is to identify and effectively inhibit the relevant source(s) of ROS in a given disease condition. A highly likely target in this context is the family of NADPH oxidases. Animal models, including NOX knockout mice and new pharmacological inhibitors of NADPH oxidases have opened up a new era of oxidative stress research and have paved the way for new cardiovascular therapies.
authors.affiliation: Department of Pharmacology & Cardiovascular Research Institute Maastricht, Maastricht University, the Netherlands.
authors.forename: K
authors.initials: K
authors.lastname: Wingler
authors.forename: J J R
authors.initials: JJ
authors.lastname: Hermans
authors.forename: P
authors.initials: P
authors.lastname: Schiffers
authors.forename: Al
authors.initials: A
authors.lastname: Moens
authors.forename: M
authors.initials: M
authors.lastname: Paul
authors.forename: H H H W
authors.initials: HH
authors.lastname: Schmidt
mesh_terms: D000818:Animals; D002317:Cardiovascular Agents / Q000494:pharmacology / Q000627:therapeutic use; D002318:Cardiovascular Diseases / Q000188:drug therapy / Q000201:enzymology / Q000378:metabolism; D006801:Humans; D019255:NADPH Oxidases / Q000037:antagonists & inhibitors* / Q000378:metabolism*; D018384:Oxidative Stress / Q000187:drug effects* / Q000502:physiology*
chemical_list: D002317:Cardiovascular Agents; D019255:NADPH Oxidases